AU7976998A - (amidino)6-membered aromatics as factor xa inhibitors - Google Patents
(amidino)6-membered aromatics as factor xa inhibitorsInfo
- Publication number
- AU7976998A AU7976998A AU79769/98A AU7976998A AU7976998A AU 7976998 A AU7976998 A AU 7976998A AU 79769/98 A AU79769/98 A AU 79769/98A AU 7976998 A AU7976998 A AU 7976998A AU 7976998 A AU7976998 A AU 7976998A
- Authority
- AU
- Australia
- Prior art keywords
- amidino
- inhibitors
- factor
- membered aromatics
- aromatics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87856297A | 1997-06-19 | 1997-06-19 | |
US08878562 | 1997-06-19 | ||
PCT/US1998/012682 WO1998057934A1 (fr) | 1997-06-19 | 1998-06-18 | Agents aromatiques a six membres amidino utiles en tant qu'inhibiteurs du facteur xa |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7976998A true AU7976998A (en) | 1999-01-04 |
Family
ID=25372285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU79769/98A Abandoned AU7976998A (en) | 1997-06-19 | 1998-06-18 | (amidino)6-membered aromatics as factor xa inhibitors |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0993448A1 (fr) |
AU (1) | AU7976998A (fr) |
CA (1) | CA2293824A1 (fr) |
WO (1) | WO1998057934A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2300699A (en) | 1998-02-17 | 1999-08-30 | Ono Pharmaceutical Co. Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
JP2002509924A (ja) | 1998-03-27 | 2002-04-02 | デュポン ファーマシューティカルズ カンパニー | 第Xa因子阻害剤としてのジ置換ピラゾリン類およびトリアゾリン類 |
US6127376A (en) * | 1998-12-04 | 2000-10-03 | Berlex Laboratories, Inc. | Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
CA2320730A1 (fr) | 1998-12-23 | 2000-07-06 | Renhua Li | Inhibiteurs du facteur xa ou de la thrombine |
JP2003522733A (ja) * | 1999-02-11 | 2003-07-29 | コア セラピューティクス,インコーポレイティド | Xa因子の阻害剤としてのアルケニルおよびアルキニル化合物 |
CA2374793A1 (fr) | 1999-05-24 | 2000-11-30 | Penglie Zhang | Inhibiteurs du facteur xa |
TR200201413T2 (tr) * | 1999-09-17 | 2003-02-21 | Millennium Pharmaceuticals, Inc. | Faktör Xa' nın inhibitörleri. |
US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US6720317B1 (en) | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
EP1216228B1 (fr) * | 1999-09-17 | 2008-10-29 | Millennium Pharmaceuticals, Inc. | BENZAMIDES ET INHIBITEURS CORRESPONDANTS DU FACTEUR Xa |
KR20020070385A (ko) * | 2000-01-29 | 2002-09-06 | 주식회사 엘지씨아이 | 아릴-아미딘을 가진 팩터 Xa 억제제와 그의 유도체, 및그의 프로드럭 |
EP1259485B1 (fr) | 2000-02-29 | 2005-11-30 | Millennium Pharmaceuticals, Inc. | Benzamides et inhibiteurs associes du facteur xa |
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
EP1296982B1 (fr) | 2000-06-23 | 2007-09-19 | Bristol-Myers Squibb Pharma Company | Derives de pyrazole condenses par 1 - (heteroaryl-phenyl) utilises comme inhibiteurs du facteur xa |
US6599926B2 (en) | 2000-06-23 | 2003-07-29 | Bristol-Myers Squibb Company | Heteroaryl-phenyl substituted factor Xa inhibitors |
DE10036852A1 (de) * | 2000-07-28 | 2002-02-07 | Merck Patent Gmbh | Urethanderivate |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
US6710061B2 (en) | 2001-03-09 | 2004-03-23 | Ortho-Mcneil Pharamceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
JP2004520438A (ja) | 2001-03-09 | 2004-07-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | セリンプロテアーゼインヒビターとしてのアミノピロリジンスルホンアミド |
CH1427415H1 (de) | 2001-09-21 | 2023-12-21 | Bristol Myers Squibb Holdings Ireland | Lactamhaltige verbindungen und ihre derivate als faktor-xa-hemmer |
TWI331526B (en) | 2001-09-21 | 2010-10-11 | Bristol Myers Squibb Pharma Co | Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
GB0124931D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124939D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124941D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124934D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124936D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124933D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124938D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
TW200302225A (en) | 2001-12-04 | 2003-08-01 | Bristol Myers Squibb Co | Substituted amino methyl factor Xa inhibitors |
WO2003048081A2 (fr) | 2001-12-04 | 2003-06-12 | Bristol-Myers Squibb Company | Glycinamides en tant qu'inhibiteurs du facteur xa |
BRPI0307351B8 (pt) | 2002-02-12 | 2021-05-25 | Smithkline Beecham Corp | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto |
AU2003273179A1 (en) | 2002-05-10 | 2003-12-12 | Bristol-Myers Squibb Company | 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
US7479502B2 (en) | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
US7122557B2 (en) | 2003-03-18 | 2006-10-17 | Bristol-Myers Squibb Company | Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors |
GB0308185D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
CN1826121B (zh) * | 2003-07-23 | 2013-05-29 | 幸讬制药公司 | 苯基与吡啶基衍生物用于制备调控钙离子释放活化钙离子通道的药物的用途 |
EP1846372B1 (fr) | 2005-01-07 | 2014-04-16 | Synta Pharmaceuticals Corp. | Composes utilises pour des etats inflammatoires et immunitaires |
CN101595092B (zh) | 2006-11-02 | 2012-02-01 | 米伦纽姆医药公司 | 合成因子xa抑制剂的医药盐的方法 |
JP2010509392A (ja) | 2006-11-13 | 2010-03-25 | ファイザー・プロダクツ・インク | ジアリール、ジピリジニルおよびアリール−ピリジニル誘導体ならびにその使用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
ES2193202T3 (es) * | 1994-12-02 | 2003-11-01 | Yamanouchi Pharma Co Ltd | Nuevo derivado de amidinonaftilo o sal de este. |
DK0813525T3 (da) * | 1995-03-10 | 2004-02-16 | Berlex Lab | Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter |
EP0874629B1 (fr) * | 1995-12-21 | 2004-05-19 | Bristol-Myers Squibb Pharma Company | ISOXAZOLINE, ISOTHIAZOLINE ET PYRAZOLINE INHIBITEURS DU FACTEUR Xa |
ES2218677T3 (es) * | 1996-04-17 | 2004-11-16 | Bristol-Myers Squibb Pharma Company | Derivados de n-(amidinofenil)-n'-(subst.)-3h-2,4-benzodiazepin-3-ona como inhibidores del factor xa. |
ATE230392T1 (de) * | 1996-08-16 | 2003-01-15 | Bristol Myers Squibb Pharma Co | Amidinophenyl-pyrrolidine, -pyrroline und - isoxazolidine und ihre derivate |
PT929547E (pt) * | 1996-09-12 | 2003-03-31 | Schering Ag | Derivados da benzamidina substituidos por derivados de aminoacidos ciclicos e de hidroxiacidos ciclicos e seu uso como anticoagulantes |
EA003056B1 (ru) * | 1996-12-23 | 2002-12-26 | Дюпон Фармасьютикалз Компани | АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ |
WO1998028282A2 (fr) * | 1996-12-23 | 1998-07-02 | Du Pont Pharmaceuticals Company | OXYGENE OU SOUFRE CONTANANT DES HETERO-AROMATIQUES UTILISES COMME INHIBITEURS DU FACTEUR Xa |
-
1998
- 1998-06-18 AU AU79769/98A patent/AU7976998A/en not_active Abandoned
- 1998-06-18 EP EP98930362A patent/EP0993448A1/fr not_active Ceased
- 1998-06-18 CA CA002293824A patent/CA2293824A1/fr not_active Abandoned
- 1998-06-18 WO PCT/US1998/012682 patent/WO1998057934A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2293824A1 (fr) | 1998-12-23 |
WO1998057934A1 (fr) | 1998-12-23 |
EP0993448A1 (fr) | 2000-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7976998A (en) | (amidino)6-membered aromatics as factor xa inhibitors | |
AU3127900A (en) | Thrombin or factor xa inhibitors | |
AU4787596A (en) | Thrombin inhibitors | |
AU6477498A (en) | Scale inhibitors | |
IL137517A0 (en) | Substituted oxoazaheterocyclyl factor xa inhibitors | |
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU6489496A (en) | Cell adhesion inhibitors | |
AU5208193A (en) | Guanidinyl-substituted heterocyclic thrombin inhibitors | |
AU7145294A (en) | Heterocyclic thrombin inhibitors | |
AU3941797A (en) | Novel thrombin inhibitors | |
AU8858398A (en) | Matrix metalloproteinase inhibitors | |
AU5129098A (en) | Complement inhibitor | |
AU4867497A (en) | 1-(4-piperdinyl)-piperidinylene as aggregation inhibitor | |
AU6090594A (en) | Angiotensin ii inhibitors | |
ZA964753B (en) | Inhibitors of Factor Xa. | |
AU6183494A (en) | Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors | |
AU2832399A (en) | B cell inhibitors | |
AU3396697A (en) | Thrombin inhibitor | |
AU8673598A (en) | Neuraminidase inhibitors | |
AU8038798A (en) | Cis-substituted fluoromethylpyrrolidine derivatives | |
AU5882298A (en) | New analgesic composition | |
AU3042697A (en) | Thrombin inhibitors | |
AU1013997A (en) | Amylase inhibitors | |
AU2908197A (en) | Thrombin inhibitors | |
AU4618197A (en) | Thrombin inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |